| Pharmaceutical active ingredients: |
| Doxorubicin Hydrochloride |
| Available forms, composition and doses of Rastocin: |
| Injectable; Injection; Doxorubicin Hydrochloride 10 mg |
| Rastocin medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01DB01 - Doxorubicin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pliva |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Neoxane | Doxorubicin Hydrochloride | Asta Medica |
| Onkodox | Doxorubicin Hydrochloride | Onkoworks Gesellschaft zur Herstellung und Vertrieb Onkologischer Spezialpraparate |
| Oxocina | Doxorubicin Hydrochloride | Baxter |
| Pallagicin | Doxorubicin Hydrochloride | Teva |
| Ranxas | Doxorubicin Hydrochloride | Sandoz |
| Ribodoxo-L | Doxorubicin Hydrochloride | Ribosepharm |
| Rubex | Doxorubicin Hydrochloride | Bristol-Myers Squibb |
| Rubidox | Doxorubicin Hydrochloride | Bergamo Laboratorio Quimico Farmaceutico |
| Sindroxocin | Doxorubicin Hydrochloride | Actavis; Firma Chun Cheong; Makiz-Pharma; Pascual Laboratories; S.C. Sindan Pharma; Zuellig Pharma |
| Lipo-Dox | Doxorubicin Hydrochloride Liposomal | American Taiwan Biopharm |